The nAMD Barometer Leadership Coalition, an international group of experts in retinal disease, vision and diabetes care, and ageing, recently validated definitions for adherence and persistence to anti-VEGF therapy in AMD. This evidence concerns the gene VEGFA and age-related macular degeneration.